Novel insomnia treatment special-effect drug

Abstract

The invention relates to a novel insomnia treatment special-effect drug, which is characterized by comprising, by weight, 20-30% of ziziphus jujuba mill.var.spinosa, 20-30% of tuber fleeceflower stem, 12-20% of codonopsis pilosula, 10-20% of milkvetch root, 10-30% of radix rehmanniae preparata, 10-30% of raw paeonia lactiflora pall, 10-20% of radix bupleuri, and 10-30% of citrus medica l. var. sarcodactylis swingle. According to the present invention, with the novel insomnia treatment special-effect drug, the problems of high side effect, long taking time, high recurrence rate after drug discontinuance and incapable cure of the modern clinical insomnia treatment drug are solved.

Description

technical field [0001] The invention relates to the field of medicine production, in particular to a novel specific drug for treating insomnia. Background technique [0002] For insomnia in modern clinics, Western medicines are often used, such as diazepam, fluazepam, and sultazepam. These medicines have relatively large side effects, take a long time, have a high recurrence rate after drug withdrawal, and cannot be cured. Contents of the invention [0003] The present invention aims to solve the problem that the existing drug treatment of insomnia has a high recurrence rate and cannot be cured, and a new type of specific drug for treating insomnia is invented. [0004] The technical solution of the present invention is a novel specific medicine for treating insomnia, comprising: [0005] Components: Suanzaoren, Nocturna, Codonopsis, Astragalus, Rehmannia, Hangbai, Bupleurum, Bergamot; [0006] Component weight ratio: Suanzaoren 20-30%, Caulis 20-30%, Codonopsis 12-20%, ...

AI Technical Summary

Problems solved by technology

[0003] In order to solve the problem that the existing drug treatment of insomnia has a high recurrence rate and cannot be cured, a new type of special drug for treating insomnia is invented.